These trials are currently recruiting participants in the UK. Always speak to your GP or specialist before contacting a trial team.
Atrial fibrillation (AF) is one of the most common cardiac arrhythmias and cardioembolic stroke due to AF is its major complication. Direct…
This is a Phase III, randomized, double-blind, parallel-group, placebo-controlled, multicenter study to investigate CV outcomes with elecoglipron compared with placebo, in adults…
Acute stress-induced (Takotsubo cardiomyopathy) presents like a heart attack and is triggered by intense emotional or physical stress. Although coronary arteries are…
There is a lack of understanding of how Coronary Artery Disease (CAD) - meaning the blocking or furring up of the arteries…
The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with oral semaglutide in adults with…
The OPTIMAL randomized clinical trial has been designed to compare two imaging strategies and to test the hypothesis that a calcium modification…
Atorvastatin is a statin medicine used to lower cholesterol and reduce the risk of heart attack…
Learn more →Living with Heart & Circulation? Your experience can help others. Share what you've learned.
Thousands of UK patients are managing Heart & Circulation. Connect, share experiences, and support each other.
The latest pipeline drugs, clinical breakthroughs, and regulatory approvals from the FDA, EMA and NICE for Heart & Circulation patients.
HTG694
📋 Information sourced from clinical trial registries, FDA, EMA and published research
View all research →No podcasts available yet for Heart & Circulation
Sign up for updates below to be notified when we release a free patient podcast for this area.